Better Alzheimer's Disease Stock: Eli Lilly or Biogen? [The Motley Fool]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: The Motley Fool
One of these stocks has significantly outperformed the other over the past year. Will that continue?Several big-name companies are racing to develop effective therapies for Alzheimer's disease (AD), a goal that has proven difficult over the years. It's no wonder that this area is attracting a lot of attention: About 5.8 million people in the U.S. had AD as of 2020. Some estimates put that number at 44 million worldwide.Two drugmakers that feature in the race to find a successful AD treatment areEli LillyLLY-0.50%BiogenBIIB-1.75%But which of these companies has the best shot at remaining a leader in this therapeutic area from here on? And which is the better buy overall? Let's dig in and find out.YChartsEli Lilly still has a long way to goEli Lilly's AD candidate, donanemab, works by targeting clusters of the beta-amyloid protein that accumulate in the brains of patients and are thought to be linked to the cognitive decline associated with the disease. In the third quarter of 2021, the
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- 3 Stocks to Buy Following Guidance Upgrades [Yahoo! Finance]Yahoo! Finance
- The finance chief of this biotech company is a Harvard-trained neuroscientist who says ‘the modern day CFO needs to speak the language of the team' [Fortune]Fortune
- Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
- Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases [Yahoo! Finance]Yahoo! Finance
- FDA Roundup: May 7, 2024 [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 5/9/24 - Form 8-K
- 5/3/24 - Form SD
- 4/30/24 - Form 10-Q
- LLY's page on the SEC website